Office-Based Intraperitoneal Chemotherapy for Ovarian Cancer

被引：5
作者：
Robinson, William R. [1 ]
Coberly, Cathy [1 ]
Beyer, Julie [1 ]
Lewis, April [1 ]
Ballard, Carrie [1 ]
机构：
[1] Texas Tech Univ, Hlth Sci Ctr, Don & Sybil Harrington Canc Ctr, Amarillo, TX USA
来源：
JOURNAL OF ONCOLOGY PRACTICE | 2008年 / 4卷 / 05期
关键词：
D O I：
10.1200/JOP.0858503
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：225 / 228
页数：4
相关论文
共 14 条
  • [1] Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer
    Alberts, DS
    Liu, PY
    Hannigan, EV
    OToole, R
    Williams, SD
    Young, JA
    Franklin, EW
    ClarkePearson, DL
    Malviya, VK
    DuBeshter, B
    Adelson, MD
    Hoskins, WJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (26) : 1950 - 1955
  • [2] Intraperitoneal cisplatin and paclitaxel in ovarian cancer
    Armstrong, DK
    Bundy, B
    Wenzel, L
    Huang, HQ
    Baergen, R
    Lele, S
    Copeland, LJ
    Walker, JL
    Burger, RA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (01) : 34 - 43
  • [3] Pharmacokinetic problems in peritoneal drug administration: Tissue penetration and surface exposure
    Dedrick, RL
    Flessner, MF
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (07): : 480 - 487
  • [4] DEDRICK RL, 1978, CANCER TREAT REP, V62, P1
  • [5] INTRAPERITONEAL CISPLATIN WITH SYSTEMIC THIOSULFATE PROTECTION
    HOWELL, SB
    PFEIFLE, CL
    WUNG, WE
    OLSHEN, RA
    LUCAS, WE
    YON, JL
    GREEN, M
    [J]. ANNALS OF INTERNAL MEDICINE, 1982, 97 (06) : 845 - 851
  • [6] Markman, 1996, Oncologist, V1, P18
  • [7] Intraperitoneal chemotherapy of ovarian cancer: A review, with a focus on practical aspects of treatment
    Markman, M
    Walker, JL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (06) : 988 - 994
  • [8] Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: An intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group
    Markman, M
    Bundy, BN
    Alberts, DS
    Fowler, JM
    Clark-Pearson, DL
    Carson, LF
    Wadler, S
    Sickel, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (04) : 1001 - 1007
  • [9] PHASE-I TRIAL OF INTRAPERITONEAL TAXOL - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    MARKMAN, M
    ROWINSKY, E
    HAKES, T
    REICHMAN, B
    JONES, W
    LEWIS, JL
    RUBIN, S
    CURTIN, J
    BARAKAT, R
    PHILLIPS, M
    HUROWITZ, L
    ALMADRONES, L
    HOSKINS, W
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (09) : 1485 - 1491
  • [10] Paclitaxel maintenance chemotherapy following intraperitoneal chemotherapy for ovarian cancer
    Robinson, W. R.
    Davis, N.
    Rogers, S.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2008, 18 (05) : 891 - 895
12